Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • CDSCO declares 5...

CDSCO declares 5 formulations as spurious: Details

Written By : Dr. Divya Colin |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 17 Jun 2024 12:30 PM  |  Updated On 17 Jun 2024 12:30 PM
Batch of Telma AM earlier classified as NSQ now flagged as Spurious
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: In the latest spurious drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has declared 5 formulations to be spurious, which include antiretrovirals, antihypertensives, NSAIDs, and antibiotics.

The list includes Instgra Tablets (Dolutegravir Tablets IP 50 mg) manufactured by as per label Emcure Pharmaceutical, Telmisartan 40 mg and Amlodipine 5 mg Tablets I.P. (TelmaAM) manufactured by as per label Glenmark Pharmaceuticals, Rifaximin Tablets (Rifagut 400) manufactured by as per label Sun Pharma laboratories, and others.

Section 17B and Section 33EEA of the Drugs Act define spurious drugs. According to the 1940 Drugs and Cosmetics Act,

"A drug shall be deemed to be spurious,—
(a) if it is manufactured under a name which belongs to another drug; or
(b) if it is an imitation of, or is a substitute for, another drug or resembles another drug in a manner likely to deceive or bears upon it or upon its label or container the name of another drug unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug; or
(c) if the label or container bears the name of an individual or company purporting to be the manufacturer of the drug , which individual or company is fictitious or does not exist; or
(d) if it has been substituted wholly or in part by another drug or substance; or (e) if it purports to be the product of a manufacturer of whom it is not truly a product."

The CDSCO recently issued an alert in which it stated that certain products, including Instgra Tablets manufactured by as per label Emcure Pharmaceutical, TelmaAM manufactured by as per label Glenmark Pharmaceuticals, Rifagut 400 manufactured by as per label Sun Pharma laboratories, Presef 200 LB Tablets manufactured by as per label Pragti Remedies and Naxdom 500 manufactured by as per label Pure and Cure Healthcare, are found to be spurious.

SPURIOUS ALERT FOR THE MONTH OF APRIL - 2024.

NCT of DELHI

S. No.

Product/Drug Name

B. No.

Manufacturing Date

Expiry

Date

Manufactured By as per label

Sales Outlets Involved in Distribution of Spurious Drugs (Name and address of outlet with pin code and pharmacist name with registration number)

Response of Original Manufacturer stating how to identify the original product from reported spurious product

Reported by CDSCO/ State/Manufacturer

1

Instgra

Tablets

(Dolutegravir Tablets IP 50 mg)

E16DV23 001

Feb.2023

Sep.2026

Emcure

Pharmaceutical s Ltd., Lane No. 3, Phase II, SIDCO, Bari- Brahmana,

Jammu - 181 133, India

1) M/s. Harsh Pharma Capital Delhi

2) M/s. Vedas Healthcare Delhi

3) M/s. Mili Healthcare Mumbai

4) M/s. Khushi Enterprises Jaipur

5) M/s. V. K. Enterprises Jaipur

Based on

physical

verification

with original product on spot and SLA email dt. May 10, 2024

NCT of

Delhi

2

Telmisartan

40mg and Amlodipine

5mg Tablets

18230073

Feb.23

Jan.26

Glenmark

Pharmaceutical s Ltd. Samlik Marchak,

1) M/s. Dass Medical Store Delhi (on direction of court)

As per SLA email dt. May 10, 2024

NCT of

Delhi

I.P. (Telma-

AM)

Industrial

Growth Centre, East Sikkim, Sikkim-737135

2) M/s. Shree Giriraj Ji Pharma Delhi

3) M/s Amba Medicose Delhi

3

Domperidone and Naproxen Sodium

Tablets

(Naxdom 500)

FHA0966

Dec.2023

Nov. 2026

Pure and Cure Healthcare Pvt. Ltd. Plot No. 26A, 27-30, Sector-8A,

I.I.E., Sidcul, Ranipur,

Haridwar-249 403

(Uttarakhand)

1) M/s. Jai Mata Di Bhagirath Palace Delhi

2) M/s. JMD Enterprises Patna

Based on

physical

comparison

and analytical tests done by manufacturer

and SLA email dt. May 10, 2024

NCT of

Delhi

4

Rifaximin

Tablets

(Rifagut 400)

GKE0938 A

June. 2023

May. 2025

Sun pharma laboratories ltd. Plot No. 754,

Setipool,

Nandok Block, R.O. Ranipool, East Sikkim- 737

1) M/s. Jai Mata Di Bhagirath Palace Delhi

2) M/s. JMD Enterprises Patna

Based on

physical

comparison

and analytical tests done by manufacturer

and SLA email dt. May 10, 2024

NCT of

Delhi

JHARKHAND

5

Cefixime

Trihydrate

with Lactic Acid Bacillus Tablets LP. (Presef 200

BHCJ-009

Nov. 2022

Oct. 2024

Pragti

Remedies Plot

No. 143 GS

Road Link

Ulubari

Guwahathi

1. M/s. Pragti

Remedies Plot No. 143 GS Road Link Ulubari Guwahathi Assam 781008;

Based on SLA email dt. May 13, 2024

SLA,

Jharkhan d

LB Tablets) ★Serial No. 14 of NSQ alert of April, 2024

Assam 781008 (This firm does not exist at the given address as per SDC, Assam vide letter no- CFDA/2019/05/ PT-1/1073, Dt. 19.03.2024)

2. M/s. Pama Pharmaceuticals Devi Mandap Road Ratu Road Ranchi;

3. M/s. Sarthak Agency Kathitand Ratu Road Ranchi;

4. M/s. Life Saver 11/1 Dewan Gazi Road Kolkata West Bengal

The notice further added,

1. Spurious Alert data was not received as per Format and in EXCEL SHEET from State Drugs Licensing Authorities of Uttar Pradesh for the Month of April 2024 as per DCG (I) Circular dated 09.02.2024.

2. Sate Drugs Licensing Authorities of Mizoram, Tripura, and Pondicherry have stated that the Spurious data as “NIL” for the Month of April, 2024.

3. State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Himachal Pradesh, Maharashtra, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Rajasthan, Sikkim, Tamil Nadu, Telangana, Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Spurious Alert for the Month of April, 2024 as per DCG(I) Circular dated 09.02.2024.

Also Read: Novartis Gets CDSCO Panel Nod to Study Iptacopan in Atypical Hemolytic Uremic Syndrome

To view the official notice, click the link below:

https://medicaldialogues.in/pdf_upload/spurious-alertaprl24-241270.pdf
spurious drugdrug alertcdscoTelmisartanAmlodipinesun pharma labsemcure pharmaglenmark-pharmaceuticals
Dr. Divya Colin
Dr. Divya Colin

    Doctor of Pharmacy

    Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Journal Club Today

    8-Minute MRI Scan May Replace Painful Lumbar Puncture for Multiple Sclerosis Diagnosis: Study Suggests

    8-Minute MRI Scan May Replace Painful Lumbar Puncture for Multiple Sclerosis Diagnosis: Study...

    View All

    Health News Today

    Health Bulletin 23/May/2025

    Health Bulletin 23/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok